Koers Stemline Therapeutics, Inc.
Aandelen
US85858C1071
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ivan Bergstein
CEO | Chief Executive Officer | 58 | 08-08-03 |
David Gionco
DFI | Director of Finance/CFO | 63 | 16-01-14 |
Jeffrey Levitt
CMP | Compliance Officer | - | 01-03-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ivan Bergstein
CEO | Chief Executive Officer | 58 | 08-08-03 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,46% | 102 mld. | |
+1,41% | 96,29 mld. | |
+2,13% | 22,18 mld. | |
-15,84% | 21,2 mld. | |
-9,21% | 18,31 mld. | |
-39,98% | 17,38 mld. | |
-14,65% | 16,36 mld. | |
+4,39% | 13,97 mld. | |
+31,35% | 12,17 mld. |